Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abivax SA Sponsored ADR (ABVX)
NASDAQ:ABVX
RESEARCH TOOLSreports
Holding ABVX?
Track your performance easily
ABVX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.00 - $17.02
Previous Close$11.37
Volume38.48K
Average Volume (3M)74.49K
Market Cap
$711.29M
Enterprise Value$2.77B
Total Cash (Recent Filing)€632.00M
Total Debt (Recent Filing)€2.63B
Price to Earnings (P/E)―
Beta0.41
Next Earnings
Nov 07, 2024EPS Estimate
-$0.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.55
Shares Outstanding62,917,479
10 Day Avg. Volume69,856
30 Day Avg. Volume74,488
Standard Deviation0.10
R-Squared0.00037
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)3.64
Price to Sales (P/S)140.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$34.17Price Target Upside195.84% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Abivax SA Sponsored ADR News
PremiumCompany Announcements
Abivax SA Details Financial Struggles and Advances
PremiumCompany Announcements
Abivax SA Reveals Soaring R&D Costs in H1 2024
PremiumPress Releases
Abivax presents first-half 2024 financial results
Bulls Say, Bears Say
Bulls Say
Enrollment ProgressThe ABTECT program is roughly 50% enrolled, with a recent acceleration in enrollment being seen across the 600 activated sites and a steady decline in screen failure rates.
LeadershipSeveral new leadership appointments were announced, including a new Chair of the Board, Chief Medical Officer, and Chief Strategy Officer.
Market OpportunityObefazimod, with its differentiated mechanism, competitive efficacy, and superior safety, is poised to emerge as a potential category leader in IBD.
Bears Say
Leadership ChangesLeadership changes highlighted include the retirement of Dr. Sheldon Sloan from his role as Chief Medical Officer and the appointment of Dr. Fabio Cataldi in his place.
Market NeedsThere is still a big unmet need for durable, safe and broadly applicable oral options in inflammatory bowel disease.
Product RisksThere are commercial, regulatory, clinical, and IP risks associated with marketed and pipeline products.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.45% Mutual Funds
37.40% Other Institutional Investors
61.15% Public Companies and
Individual Investors
ABVX FAQ
What was Abivax SA Sponsored ADR’s price range in the past 12 months?
Abivax SA Sponsored ADR lowest stock price was $8.00 and its highest was $17.02 in the past 12 months.
What is Abivax SA Sponsored ADR’s market cap?
Currently, no data Available
When is Abivax SA Sponsored ADR’s upcoming earnings report date?
Abivax SA Sponsored ADR’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were Abivax SA Sponsored ADR’s earnings last quarter?
Abivax SA Sponsored ADR released its earnings results on Sep 09, 2024. The company reported -$0.723 earnings per share for the quarter, missing the consensus estimate of -$0.718 by -$0.005.
Is Abivax SA Sponsored ADR overvalued?
According to Wall Street analysts Abivax SA Sponsored ADR’s price is currently Undervalued.
Does Abivax SA Sponsored ADR pay dividends?
Abivax SA Sponsored ADR does not currently pay dividends.
What is Abivax SA Sponsored ADR’s EPS estimate?
Abivax SA Sponsored ADR’s EPS estimate is -$0.72.
How many shares outstanding does Abivax SA Sponsored ADR have?
Abivax SA Sponsored ADR has 63,294,655 shares outstanding.
What happened to Abivax SA Sponsored ADR’s price movement after its last earnings report?
Abivax SA Sponsored ADR reported an EPS of -$0.723 in its last earnings report, missing expectations of -$0.718. Following the earnings report the stock price went down -2%.
Which hedge fund is a major shareholder of Abivax SA Sponsored ADR?
Among the largest hedge funds holding Abivax SA Sponsored ADR’s share is Blackstone Inc.. It holds Abivax SA Sponsored ADR’s shares valued at 25M.
---
Abivax SA Sponsored ADR Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$34.17 (195.84% Upside)
$34.17 (195.84% Upside)
Hedge Fund Trend
Decreased
By 224.3K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-171.78%
Trailing 12-Months
Asset Growth
63.36%
Trailing 12-Months
Company Description
Abivax SA Sponsored ADR
Abivax is focused on developing innovative treatments that harness the body¿s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
---
ABVX Stock 12 Month Forecast
Average Price Target
$34.17
▲(195.84% Upside)
Technical Analysis
Best Analysts Covering ABVX
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
-9.55%
reiterated a buy rating 2 months ago
Copying Sam Slutsky's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -9.55% per trade.
---